Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
VBY-825 is a novel, reversible cathepsin inhibitor which has high potency against cathepsins B, L, S and V. VBY-825 is also a new and effective anti-tumor drug.
?您的位置：
